Dated 16 February 2012 QUOTIENT BIODIAGNOSTICS HOLDINGS LIMITED and PAUL COWAN SERVICE AGREEMENT Speechly Bircham LLP London EC4A 3LX Tel: +44 (0)20 7427 6400 Fax: +44 (0)20 7427 6600 Ref 344087Service Agreement • January 22nd, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
EMPLOYMENT AGREEMENTEmployment Agreement • January 22nd, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances • New Jersey
This Employment Agreement (“Employment Agreement”) is entered into as of March 9, 2009 (the “Effective Date”), by and between Alba Bioscience Limited (“Employer”), or such affiliate of Employer as its Chairman may designate, and Jeremy Stackawitz (“Executive”) (collectively, the “Parties”).
Quotient Biodiagnostics Holdings Limited SHAREHOLDERS AGREEMENTShareholder Agreement • January 22nd, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances • Jersey
THIS SHAREHOLDERS AGREEMENT (this “Agreement”) is made as of the 16 day of February, 2012, by and among Quotient Biodiagnostics Holdings Limited, a no par value liability company incorporated in Jersey, Channel Islands with registered number 109886 (the “Corporation”), each holder of the Corporation’s A Preference Shares (“Series A Preferred”) and B Preference Shares (“Series B Preferred” and together with the Series A Preferred, the “Preferred Stock”) listed on Schedule A hereto (the “Investors”), and the holders of the Corporation’s Ordinary Shares, A Deferred Shares, B Deferred Shares, C Deferred Shares, A Ordinary Shares and B Ordinary Share (collectively, the “Common Stock”) listed on Schedule B hereto (the “Key Holders” and together with the Investors, the “Shareholders”).
LEASE AGREEMENT (the “Agreement” or the “Lease”) dated as of 10th March 2010 by and betweenLease Agreement • January 22nd, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
Nemaco Fléchères B.V., a company constituted under the laws of the Netherlands whose registered office is at Diepenbrockstraat 54, 1077WB, Amsterdam, Netherlands
